Corium International, Inc. develops and manufactures products based on its advanced transdermal drug delivery technologies. The company has developed two highly differentiated state of the art transdermal technologies: MicroCor® is designed for needle-free active delivery of large molecules such as vaccines, proteins and peptides, and Corplex™ enables passive delivery of small molecules that may otherwise be difficult to formulate and deliver. The two technologies expand the universe of drugs and biologicals that can be delivered through the skin. The company collaborates with partners in developing and commercializing their proprietary molecules and is also developing its own proprietary pipeline.